Functional Fluidics specializes in the development and validation of biomarkers that assess red blood cell (RBC) health, particularly focusing on conditions such as Sickle Cell Disease. The company offers a suite of proprietary assays designed to evaluate various aspects of RBC function, including flow adhesion, mechanical fragility, and dynamic sickling. These assays are crucial for clinical providers, pharmaceutical companies, and academic institutions, as they provide insights into patient-level responses and support drug development and personalized medical applications. The lab is CLIA-certified, ensuring high standards in diagnostic testing and research.

In addition to its diagnostic services, Functional Fluidics also provides contract research services tailored to the needs of pharmaceutical and biotech companies. Their proprietary assays can validate clinical claims and assumptions, making them valuable tools in pre-clinical, clinical, and post-marketing research stages. The company aims to improve patient care and outcomes by offering innovative solutions that enhance the understanding of RBC health and function, thereby addressing significant gaps in current healthcare practices.

United States

Functional Fluidics is a healthcare company that provides a testing platform to assess the health of red blood cells, crucial for oxygen delivery to organs.

Functional Fluidics

Company Details